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Editorial
Cosmetovigilance: A New Concept for the
Residency Curriculum
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While delivering patient care, assuring the safe
use of medications is essential for good clinical
practice. However, the concept of patient
safety is not limited to medications. In recent
years, new terms have been introduced to
extend the concept of the safe use of herbal
medicine (phytovigilance, herbavigilance) and
cosmetics (cosmetovigilance).1
As defined by the World Health Organization
(WHO), “pharmacovigilance” is the sum
of the activities related to the collection,
detection, assessment, monitoring and
prevention of adverse reactions occurring
with medications.2 As mentioned above, the
spectrum of “-vigilance” has been extended to
address the safe use of herbal products and
also cosmetic products.3 These new concepts
are important to public health. We recently
published a systematic review on this topic,
which highlights the difference between
the regulations in Europe, the U.S., Canada
and other regions.1 The misidentification and

underreporting of cosmetic-related adverse
effects is a worldwide issue.
Even though cosmetic products are usually
well-tolerated, the undesirable side effects
seen with medicine can also be seen with
cosmetics and toiletries. Adverse event reports
are important to initiate a signal for potential
risks. Furthermore, validation, assessment of
causality, frequency and severity, and benefits
and risks are important since they may result
in eventual changes to product information,
safety alerts or recalls.1 However, identifying
these effects is challenging due to the limited
information available as well as the need to
validate the reports.3 While the absence of
well-established cosmetovigilance systems is a
limitation, the other problem is underreporting
by health professionals. There have been
reports that the adverse effects of cosmetics
and toiletries are underestimated, even when
consumers seek medical consultation.4 On the
other hand, the quantity and the quality of
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Figure 1. U.S. FDA webpage for submitting Adverse Event Reports (screenshot accessed on
3/10/2020 at https://www.accessdata.fda.gov/scripts/medwatch/index.cfm)
One of the methods below can be used to submit voluntary adverse event reports to the FDA:
1. Report Online via the MedWatch website;
2. Call the FDA at 1-800-FDA-1088 to report by telephone;
3. Fill the Reporting Form FDA 3500 and send by fax or mail.
reports can be improved by several methods,
which all involve training.5
In the U.S., adverse effects are reported to
the U.S. Food and Drug Administration (FDA)
MedWatch System.6 (Figure 1) However, this
novel concept is unfamiliar to most health care
professionals, including physicians. With this
evolving area of patient safety, the need to
integrate cosmetovigilance into the residency
curriculum has emerged. More specifically,
primary care physicians must incorporate
cosmetovigilance into their curriculum to
increase residents’ awareness of adverse
reactions induced by the use of cosmetic
products, as well as to promote good reporting
behavior.
Effective curriculum development requires
a determination of both content and
implementation.7 While it is important to
integrate the basics of cosmetovigilance into
the curriculum, the curriculum still needs to
cover the current policies and practices of the
country.
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Cosmetovigilance curriculum content needs to
include clinical education on the identification
of potential cosmetic adverse reactions. The
ambulatory setting is best suited for pattern
recognition of the primarily dermatologic
adverse effects associated with cosmetic use.
Within the current Family Medicine Residency
curriculum, there are two opportunities for
this to be accomplished: 1) the dermatology
rotation and 2) the continuity ambulatory
practice. Brief didactics highlighting common
cosmetic adverse events may accompany the
clinical educational experience. Additionally,
formal education on the use of the FDA
MedWatch System should be required
and implemented through the research
department. Awareness of this valuable
reporting system is the key to having a bigger
impact on a national platform. Filling this gap
in current family medicine graduate training
will serve the long-term purpose of improving
the recognition of the adverse effects of
cosmetic products and also help to improve the
regulation of this market in the future.
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